Mechanistic comparison of Dutasteride and alyssin [Supplementary Concept] based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
11%
Jaccard Similarity
12%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Dutasteride and alyssin share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.111 means 11% of the combined target set is bound by both compounds. The IDF-weighted score of 0.117 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Dutasteride and alyssin have in common?
Dutasteride and alyssin share 2 molecular targets with a Jaccard similarity of 11%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Dutasteride and alyssin be combined?
Dutasteride and alyssin share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Dutasteride or alyssin?
Both Dutasteride and alyssin have substantial PubMed research. View their individual profiles for full evidence scores.